Send us Feedback

Halozyme Therapeutics (HALO)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2012		 30-JUN
2012		 30-SEP
2012		 31-DEC
2012		 31-MAR
2013
Cash & Equivalents 117M 102M 87.6M 99.9M 39.0M
Short Term Investments 0 0 0 0 48.4M
Accounts Receivable 5.55M 5.69M 4.46M 15.7M 10.4M
Inventories 1.50M 1.78M 2.19M 2.67M 2.74M
Pre-paid Expenses 8.91M 10.2M 11.4M 12.8M 10.6M
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 0 0 0 0 0
Total Current Assets 133M 120M 106M 131M 111M
Property, Plant & Equipment 2.15M 2.02M 2.36M 3.70M 3.98M
Goodwill & Intangibles 0 0 0 0 0
Other Long-term Assets 0 0 0 0 1.78M
Total Long-Term Assets 2.15M 2.02M 2.36M 3.70M 5.76M
Total Assets 135M 122M 108M 135M 117M
Accounts Payable 3.01M 2.09M 3.53M 2.27M 2.88M
Accrued Expenses 0 0 0 0 0
Short Term Debt 0 0 0 0 1.36M
Other Current Liabilities 6.48M 6.53M 9.47M 8.89M 6.33M
Total Current Liabilities 16.7M 16.1M 21.0M 18.9M 19.8M
Long Term Debt 0 0 0 29.7M 28.3M
Capital Lease Obligations 0 0 0 0 1.45M
Deferred Income Tax 0 0 871K 0 0
Other Long-term Liabilities 37.0M 36.4M 34.9M 37.3M 35.7M
Total Long-term Liabilities 37.0M 36.4M 35.8M 66.9M 65.4M
Minority Interest 0 0 0 0 0
Total Liabilities 53.7M 52.5M 56.8M 85.9M 85.2M
Preferred Stock 0 0 0 0 0
Common Par 112K 113K 113K 113K 113K
Additional Paid-In Capital 341M 343M 345M 347M 349M
Retained Earnings -260M -274M -294M -299M -318M
Treasury Stock 0 0 0 0 0
Other Equity 0 0 0 0 -29.1K
Total Shareholder's Equity 81.1M 69.2M 51.2M 48.9M 31.7M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki